{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:05:01Z","timestamp":1780351501840,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jdiacomp.2022.108312","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T20:43:49Z","timestamp":1664052229000},"page":"108312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study"],"prefix":"10.1016","volume":"36","author":[{"given":"Tomomichi","family":"Iida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Hosojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Kabasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Yamamoto-Kabasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawako","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shino","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Kaseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2022.108312_bb0005","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.2337\/dc19-S011","article-title":"Microvascular complications and foot care: standards of medical care in diabetes\u20142019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0010","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: a report from an ADA consensus conference","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0015","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1046\/j.1523-1755.2003.00885.x","article-title":"The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study","volume":"63","author":"Keane","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0020","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/ki.1995.238","article-title":"Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy","volume":"47","author":"Hansen","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11684-017-0542-7","article-title":"Normoalbuminuric diabetic kidney disease","volume":"11","author":"Chen","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0030","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2337\/db16-0796","article-title":"Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease","volume":"66","author":"Gilbert","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0035","doi-asserted-by":"crossref","first-page":"R1009","DOI":"10.1152\/ajpregu.00809.2010","article-title":"The proximal tubule in the pathophysiology of the diabetic kidney","volume":"300","author":"Vallon","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.ackd.2014.03.006","article-title":"Glomerular and tubular function in the diabetic kidney","volume":"21","author":"Blantz","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0045","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1681\/ASN.2015020190","article-title":"Megalin-mediated tubuloglomerular alterations in high-fat diet-induced kidney disease","volume":"27","author":"Kuwahara","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0050","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.ekir.2021.01.012","article-title":"Evaluation of urinary biomarkers of proximal tubular injury, inflammation, and fibrosis in patients with albuminuric and nonalbuminuric diabetic kidney disease","volume":"6","author":"Phanish","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0055","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.ekir.2021.03.879","article-title":"Beyond the glomerulus-kidney tubule markers and diabetic kidney disease progression","volume":"6","author":"Bullen","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0060","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.1073\/pnas.91.21.9725","article-title":"Complete cloning and sequencing of rat gp330\/\"megalin,\" a distinctive member of the low density lipoprotein receptor gene family","volume":"91","author":"Saito","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/membranes4030333","article-title":"The endocytic receptor megalin and its associated proteins in proximal tubule epithelial cells","volume":"4","author":"De","year":"2014","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/dmrr.233","article-title":"The AGE-receptor in the pathogenesis of diabetic complications","volume":"17","author":"Vlassara","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrm778","article-title":"Megalin and cubilin: multifunctional endocytic receptors","volume":"3","author":"Christensen","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/labinvest.3700240","article-title":"Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules","volume":"85","author":"Oyama","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0085","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2337\/dc11-1684","article-title":"Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes","volume":"35","author":"Ogasawara","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0090","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/db16-1031","article-title":"Exocytosis-mediated urinary full-length megalin excretion is linked with the pathogenesis of diabetic nephropathy","volume":"66","author":"De","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00467-016-3535-x","article-title":"Decreased urinary excretion of the ectodomain form of megalin (A-megalin) in children with OCRL gene mutations","volume":"32","author":"Suruda","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0100","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0105","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","article-title":"GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration","volume":"64","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","article-title":"Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency","volume":"75","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0120","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2019010007","article-title":"GFR slope as a surrogate end point for kidney disease progression in clinical trials: a meta-analysis of treatment effects of randomized controlled trials","volume":"30","author":"Inker","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0125","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1681\/ASN.2019010008","article-title":"Evaluating glomerular filtration rate slope as a surrogate end point for ESKD in clinical trials: an individual participant meta-analysis of observational data","volume":"30","author":"Grams","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107805","article-title":"Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy","volume":"155","author":"Gao","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51207-8","article-title":"Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study","volume":"9","author":"Fujita","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107848","article-title":"Urinary adiponectin excretion is an early predictive marker of the decline of the renal function in patients with diabetes mellitus","volume":"35","author":"Ishizu","year":"2021","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108082","article-title":"Potential biomarkers for early detection of diabetic kidney disease","volume":"161","author":"Hussain","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000902","article-title":"Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan","volume":"8","author":"Yoshida","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0155","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2215\/CJN.01130121","article-title":"Ertugliflozin and slope of chronic eGFR: prespecified analyses from the randomized VERTIS CV trial","volume":"16","author":"Cherney","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0160","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1681\/ASN.2018010103","article-title":"Empagliflozin and kidney function decline in patients with type 2 diabetes: a slope analysis from the EMPA-REG OUTCOME trial","volume":"29","author":"Wanner","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0165","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0170","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/liv.14482","article-title":"Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B","volume":"40","author":"Ogawa","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0175","doi-asserted-by":"crossref","first-page":"74","DOI":"10.34067\/KID.0003912021","article-title":"Albuminuria within the Normal range can predict all-cause mortality and cardiovascular mortality","volume":"3","author":"Kang","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0180","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1523-1755.2001.059002702.x","article-title":"Progression of diabetic nephropathy","volume":"59","author":"Hovind","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0185","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/tra.12160","article-title":"The cellular and physiological functions of the Lowe syndrome protein OCRL1","volume":"15","author":"Mehta","year":"2014","journal-title":"Traffic"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0190","first-page":"532","article-title":"Urinary megalin in association with progression factors of diabetic nephropathy","volume":"120","author":"Akour","year":"2019","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114400","article-title":"Significance of urinary full-length megalin in patients with IgA nephropathy","volume":"9","author":"Seki","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0200","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/pr.2017.276","article-title":"Urinary C-megalin for screening of renal scarring in children after febrile urinary tract infection","volume":"83","author":"Yamanouchi","year":"2018","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0205","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000488470","article-title":"Urinary iron excretion is associated with urinary full-length megalin and renal oxidative stress in chronic kidney disease","volume":"43","author":"Nakatani","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0210","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ndt\/gfx321","article-title":"Reduced proximal tubular expression of protein endocytic receptors in proteinuria is associated with urinary receptor shedding","volume":"33","author":"Fatah","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1507\/endocrj.EJ14-0335","article-title":"Ameliorated pancreatic β cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin","volume":"62","author":"Takahara","year":"2015","journal-title":"Endocr J"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0220","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1124\/jpet.113.203869","article-title":"Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats","volume":"345","author":"Kojima","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jdiacomp.2022.108312_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154405","article-title":"Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy","volume":"113","author":"Otomo","year":"2020","journal-title":"Metabolism"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722002240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722002240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:16:45Z","timestamp":1761005805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872722002240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1056872722002240"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108312","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"108312"}}